Michael C. Riddell, Louisa van den Boom, Simon Heller, Peter G. Jacobs, Richard M. Bergenstal, Pieter Gillard, Carine de Beaufort, Martin Tauschmann, Max L. Eckstein, Tadej Battelino, Othmar Moser, Chantal Mathieu, Dessi P. Zaharieva, Richard M. Bracken, Harald Sourij, Peter Adolfsson, Carmel E. Smart, Nick Oliver, Christoph Stettler, Hood Thabit, Rémi Rabasa-Lhoret, Tim Heise, Julia K. Mader, Eda Cengiz, Lalantha Leelarathna, Aaron J. Kowalski, Kirsten Nørgaard, Bruce A. Buckingham, Asma Deeb, Emma G. Wilmot, Pathology/molecular and cellular medicine, Diabetes Pathology & Therapy, and Diabetes Clinic
Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and duration of the type of exercise. Understandably, fear of hypoglycaemia is one of the strongest barriers to incorporating exercise into daily life. Risk of hypoglycaemia during and after exercise can be lowered when insulin-dose adjustments are made and/or additional carbohydrates are consumed. Glycaemic management during exercise has been made easier with continuous glucose monitoring (CGM) and intermittently scanned continuous glucose monitoring (isCGM) systems; however, because of the complexity of CGM and isCGM systems, both individuals with type 1 diabetes and their healthcare professionals may struggle with the interpretation of given information to maximise the technological potential for effective use around exercise (ie, before, during and after). This position statement highlights the recent advancements in CGM and isCGM technology, with a focus on the evidence base for their efficacy to sense glucose around exercise and adaptations in the use of these emerging tools, and updates the guidance for exercise in adults, children and adolescents with type 1 diabetes. ispartof: PEDIATRIC DIABETES vol:21 issue:8 pages:1375-1393 ispartof: location:Denmark status: published